Skip to main content

Table 2 Type of intervention, number of drug use days, and abstinent days using zero-inflated models

From: The outcome of integrated motivational interviewing and cognitive-behavioral therapy in Egyptian patients with substance use disorder

Parameter

Days of use among all participants (count portion)

Logistic portion predicting nonuse

B (SE)

P

IRR

B (SE)

P

OR

3 months

Intercept

2.40 (0.61)

< .001**

10.72

4.66 (3.09)

0.13

105.9

Mode of treatment (MICBT)

− 0.35 (0.13)

0.006*

0.71

2.55 (0.86)

0.003*

12.85

Age

0.013 (0.009)

0.15

1.01

0.06 (0.05)

0.23

1.06

Personality disorder

− 0.22 (0.17)

0.21

0.79

2.45 (1.57)

0.12

11.62

Education, educated = 1

0.11 (0.14)

0.44

1.11

0.89 (1.10)

0.41

2.44

ASI severity of psychiatric problems

0.11 (0.05)

0.02*

1.11

− .65 (0.50)

0.19

0.52

ASI severity of medical problems

0.01 (0.04)

0.73

1.01

− .27 (0.37)

0.46

0.75

ASI severity of drug problems

− 0.02 (0.06)

0.68

0.96

− .24 (0.40)

0.54

0.78

ASI severity of employment problems

− 0.07 (0.04)

0.04

0.92

− .23 (0.25)

0.37

0.79

ASI severity of family problems

0.21 (0.03)

< .001**

0.96

− .70 (0.26)

0.009*

0.49

Log (theta)

2.60 (0.33)

< .001**

    

6 months

Intercept

3.15 (0.32)

< .001**

21.47

1.56 (3.06)

0.60

4.79

Mode of treatment MICBT = 1

− 0.33 (0.07)

< .001**

0.70

2.83 (1.06)

0.008*

16.99

Age

0.002 (0.005)

0.73

1.001

0.06 (0.05)

0.26

1.06

Personality disorder

− 0.31 (0.10)

0.002*

0.69

− 0.67 (1.46)

0.64

0.50

Education, educated = 1

− 0.05 (0.08)

0.47

0.94

1.67 (1.37)

0.22

5.32

ASI severity of psychiatric problems

0.08 (0.03)

0.006

1.09

− .10 (0.49)

0.83

0.89

ASI severity of medical problems

0.02 (0.02)

0.43

1.02

− .62 (0.46)

0.17

0.53

ASI severity of drug problems

0.007 (0.04)

0.85

1.01

− .032 (0.46)

0.94

0.96

ASI severity of employment problems

− 0.004 (0.02)

0.85

1.001

0.18 (0.27)

0.50

1.20

ASI severity of family problems

0.12 (0.01)

< .001**

1.14

− .72 (0.32)

0.02

0.48

Log (theta)

3.81 (0.41)

< .001**

    
  1. B, the regression coefficient estimates. B can be interpreted as the amount of increase (or decrease, if the sign of the coefficient is negative) in the predicted log odds of the number of zero use days “abstinent days”/and increase (or decrease if negative) in days of use between substance users when using MICBT intervention holding all other predictors constant. OR (exp B), odds ratios. The OR can be interpreted as the increase (above 1.0) or decrease (below 1.0) in the odds of not using days between MICBT participants (with other predictors in the model held constant)
  2. IRR, incidence rate ratio. The IRR can be interpreted as a percentage increase (above 1.0) or decrease (below 1.0) in drug use days with participants of the MICBT group
  3. *Significant P value (< 0.05)
  4. **Highly significant P value (< .001)